Lisa Åkesson

No excess long‐term mortality in stage I‐IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius et al. · British Journal of Haematology · 2019 · 21 citations

ABCB1 single-nucleotide variants and survival in patients with glioblastoma treated with radiotherapy concomitant with temozolomide

Annika Malmström, M Łysiak, Lisa Åkesson et al. · The Pharmacogenomics Journal · 2019 · 17 citations

Neuro-oncology, Abcb1 Single-nucleotide Variants, Glioma +9

“Do I want to know it all?” A qualitative study of glioma patients’ perspectives on receiving information about their diagnosis and prognosis

Annika Malmström, Lisa Åkesson, Peter Milos et al. · Supportive Care in Cancer · 2020 · 17 citations · Full text

Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma – The predictive significance of B blood group

Menikae K. Heenkenda, Annika Malmström, Munila Mudaisi et al. · Thrombosis Research · 2019 · 16 citations · Full text

Thrombosis, Venous Thrombosis, Non-genetic Risk Factors +11

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Ingemar Lagerlöf, Helena Fohlin, Gunilla Enblad et al. · Journal of Clinical Oncology · 2022 · 15 citations · Full text